We, therefore, isolated primary CD34+ leukemic blasts from newly diagnosed AML patients who were homozygous for C1, and matched them with C1/C1 healthy donor NK cells in a degranulation assay. The gene discussed is CD34; the disease is acute myeloid leukemia.